Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Teladoc HealthSTU:4LL +2.22%51 EV-to-EBIT is -9.19 as of Aug. 02, 2026. GuruFocus rates STU:4LL with a GF Score™ of 51/100 and a GF Value™ of €47.55 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Teladoc Health ranks worse than 212314.01% on this metric.
The historical rank and industry rank for Teladoc Health's EV-to-EBIT or its related term are showing as below:
STU:4LL'
s EV-to-EBIT Range Over the Past 10 Years
Min: -251.19 Med: -20.7 Max: -0.61
Current: -9.11
During the past 13 years, the highest EV-to-EBIT of Teladoc Health was -0.61. The lowest was -251.19. And the median was -20.70.
STU:4LL's EV-to-EBIT is ranked worse than 100% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.84
vs STU:4LL: -9.11
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Teladoc Health's Enterprise Value for the quarter that ended in Jun. 2026 was €1,582 Mil.
Teladoc Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-140 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teladoc Health EV-to-EBIT Related Terms
Teladoc Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Teladoc Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:4LL vs OMCL, OMDA, CERT: EV-to-EBIT Comparison
For the Health Information Services subindustry, Teladoc Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teladoc Health EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Teladoc Health's EV-to-EBIT falls into.
Teladoc Health's current Enterprise Value is €1,285 Mil.
Teladoc Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-140 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teladoc Health (STU:4LL) has a EV-to-EBIT of -9.19 as of Aug. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Teladoc Health and its competitors. According to the industry distribution chart, Teladoc Health ranks #999999 out of 471 companies in the Healthcare Providers & Services industry.
Is Teladoc Health's EV-to-EBIT too high?
Teladoc Health's current EV-to-EBIT is -9.19. Based on the distribution chart, Teladoc Health ranks #999999 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Teladoc Health has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Teladoc Health's EV-to-EBIT compare to OMCL and OMDA?
According to the Healthcare Providers & Services industry distribution chart, Teladoc Health ranks #999999 out of 471 companies for EV-to-EBIT. This places Teladoc Health in the lower half of its industry. The industry median EV-to-EBIT is 15.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.84, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Teladoc Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teladoc Health's current EV-to-EBIT is -9.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teladoc Health stock overvalued right now?
Based on GuruFocus' analysis, Teladoc Health (STU:4LL) is currently considered Possible Value Trap. The stock's GF Value™ is €47.55, compared to a current price of €5.81 — trading 87.8% below its estimated fair value. The current EV-to-EBIT is -9.19. Teladoc Health's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Teladoc Health (STU:4LL), the current EV-to-EBIT is -9.19 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Teladoc Health (STU:4LL) Overvalued in 2026?
Based on GuruFocus' analysis, Teladoc Health stock appears to be undervalued.
The current stock price of €5.81 is trading 87.8% below its estimated GF Value™ of €47.55.
GuruFocus considers Teladoc Health to be Possible Value Trap.
Key valuation signals for STU:4LL:
EV-to-EBIT: -9.19
GF Value™: €47.55 vs. price of €5.81 (87.8% below fair value)
No single metric tells the full story. See the STU:4LL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
51GF Score
Get the complete analysis for STU:4LL
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:4LL has been successfully added to your 
